BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19213841)

  • 1. Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.
    Tremblay F; Richard AM; Will S; Syed J; Stedman N; Perreault M; Gimeno RE
    Endocrinology; 2009 Jun; 150(6):2586-95. PubMed ID: 19213841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction.
    Holst B; Egerod KL; Jin C; Petersen PS; Østergaard MV; Hald J; Sprinkel AM; Størling J; Mandrup-Poulsen T; Holst JJ; Thams P; Orskov C; Wierup N; Sundler F; Madsen OD; Schwartz TW
    Endocrinology; 2009 Jun; 150(6):2577-85. PubMed ID: 19213833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity.
    Verhulst PJ; Lintermans A; Janssen S; Loeckx D; Himmelreich U; Buyse J; Tack J; Depoortere I
    J Neuroendocrinol; 2011 Jun; 23(6):490-500. PubMed ID: 21470317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
    Reimer MK; Ahrén B
    Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
    Takahashi E; Ito M; Miyamoto N; Nagasu T; Ino M; Tanaka I
    Int J Mol Med; 2005 Jun; 15(6):937-44. PubMed ID: 15870896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.
    Fjellström O; Larsson N; Yasuda S; Tsuchida T; Oguma T; Marley A; Wennberg-Huldt C; Hovdal D; Fukuda H; Yoneyama Y; Sasaki K; Johansson A; Lundqvist S; Brengdahl J; Isaacs RJ; Brown D; Geschwindner S; Benthem L; Priest C; Turnbull A
    PLoS One; 2015; 10(12):e0145849. PubMed ID: 26720709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase C-β1 potentiates glucose-stimulated insulin secretion.
    Hwang HJ; Yang YR; Kim HY; Choi Y; Park KS; Lee H; Ma JS; Yamamoto M; Kim J; Chae YC; Choi JH; Cocco L; Berggren PO; Jang HJ; Suh PG
    FASEB J; 2019 Oct; 33(10):10668-10679. PubMed ID: 31268747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX6 attenuates glucose-stimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice.
    Iguchi H; Ikeda Y; Okamura M; Tanaka T; Urashima Y; Ohguchi H; Takayasu S; Kojima N; Iwasaki S; Ohashi R; Jiang S; Hasegawa G; Ioka RX; Magoori K; Sumi K; Maejima T; Uchida A; Naito M; Osborne TF; Yanagisawa M; Yamamoto TT; Kodama T; Sakai J
    J Biol Chem; 2005 Nov; 280(45):37669-80. PubMed ID: 16148004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism.
    Petersen PS; Jin C; Madsen AN; Rasmussen M; Kuhre R; Egerod KL; Nielsen LB; Schwartz TW; Holst B
    FASEB J; 2011 Nov; 25(11):3803-14. PubMed ID: 21784784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary oxidised frying oil causes oxidative damage of pancreatic islets and impairment of insulin secretion, effects associated with vitamin E deficiency.
    Chiang YF; Shaw HM; Yang MF; Huang CY; Hsieh CH; Chao PM
    Br J Nutr; 2011 May; 105(9):1311-9. PubMed ID: 21205372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR120 protects lipotoxicity-induced pancreatic β-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.
    Wang Y; Xie T; Zhang D; Leung PS
    Clin Sci (Lond); 2019 Jan; 133(1):101-116. PubMed ID: 30523046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.
    Tan CP; Feng Y; Zhou YP; Eiermann GJ; Petrov A; Zhou C; Lin S; Salituro G; Meinke P; Mosley R; Akiyama TE; Einstein M; Kumar S; Berger JP; Mills SG; Thornberry NA; Yang L; Howard AD
    Diabetes; 2008 Aug; 57(8):2211-9. PubMed ID: 18477808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1.
    Wei J; Ding D; Wang T; Liu Q; Lin Y
    FASEB J; 2017 Dec; 31(12):5184-5195. PubMed ID: 28774890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis.
    Moran BM; Abdel-Wahab YH; Vasu S; Flatt PR; McKillop AM
    Acta Diabetol; 2016 Apr; 53(2):279-93. PubMed ID: 26112416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice.
    Imai Y; Patel HR; Hawkins EJ; Doliba NM; Matschinsky FM; Ahima RS
    Endocrinology; 2007 Dec; 148(12):5716-23. PubMed ID: 17717054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
    Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.
    Alquier T; Peyot ML; Latour MG; Kebede M; Sorensen CM; Gesta S; Ronald Kahn C; Smith RD; Jetton TL; Metz TO; Prentki M; Poitout V
    Diabetes; 2009 Nov; 58(11):2607-15. PubMed ID: 19720802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
    Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
    Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
    Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.